Tarsus Pharmaceuticals Correlations

TARS Stock

USD 42.36 0.18 0.43%

The current 90-days correlation between Tarsus Pharmaceuticals and Edgewise Therapeutics is -0.12 (i.e., Good diversification). The correlation of Tarsus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Tarsus Pharmaceuticals Correlation With Market

Modest diversification

The correlation between Tarsus Pharmaceuticals and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Tarsus Stock

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tarsus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Tarsus Stock please use our How to Invest in Tarsus Pharmaceuticals guide.

Moving together with Tarsus Stock

0.77

MSB

Mesabi Trust

Pair Corr

Moving against Tarsus Stock

0.91	CSCO	Cisco Systems	Pair Corr
0.91	IBM	International Business Earnings Call Tomorrow	Pair Corr
0.9	MSFT	Microsoft Aggressive Push	Pair Corr
0.87	AXP	American Express	Pair Corr
0.87	JPM	JPMorgan Chase Sell-off Trend	Pair Corr
0.86	GE	GE Aerospace Earnings Call Today	Pair Corr
0.85	CAT	Caterpillar	Pair Corr
0.8	BA	Boeing Earnings Call This Week	Pair Corr
0.77	MMM	3M Company	Pair Corr
0.76	KMDA	Kamada	Pair Corr
0.72	PFE	Pfizer Inc	Pair Corr
0.7	DD	Dupont De Nemours Earnings Call This Week	Pair Corr
0.6	NTNX	Nutanix	Pair Corr
0.55	XOM	Exxon Mobil Corp	Pair Corr
0.49	NKTR	Nektar Therapeutics	Pair Corr
0.44	T	ATT Inc Earnings Call Tomorrow	Pair Corr
0.41	HD	Home Depot	Pair Corr

Related Correlations Analysis

	VRCA	IVA	EWTX	VIGL	PRAX	FDMT	PHAT	INBX
VRCA		-0.43	-0.37	0.61	0.83	0.7	0.62	0.89	VRCA
IVA	-0.43		0.37	-0.43	-0.28	-0.29	-0.4	-0.27	IVA
EWTX	-0.37	0.37		-0.25	-0.21	-0.01	-0.29	-0.37	EWTX
VIGL	0.61	-0.43	-0.25		0.73	0.81	0.76	0.63	VIGL
PRAX	0.83	-0.28	-0.21	0.73		0.83	0.71	0.92	PRAX
FDMT	0.7	-0.29	-0.01	0.81	0.83		0.83	0.7	FDMT
PHAT	0.62	-0.4	-0.29	0.76	0.71	0.83		0.65	PHAT
INBX	0.89	-0.27	-0.37	0.63	0.92	0.7	0.65		INBX
	VRCA	IVA	EWTX	VIGL	PRAX	FDMT	PHAT	INBX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

INBX	+ 0.92	PRAX
INBX	+ 0.89	VRCA
PRAX	+ 0.83	VRCA
FDMT	+ 0.83	PRAX
PHAT	+ 0.83	FDMT
FDMT	+ 0.81	VIGL

High negative correlations

VIGL	- 0.43	IVA
IVA	- 0.43	VRCA
PHAT	- 0.4	IVA
INBX	- 0.37	EWTX
EWTX	- 0.37	VRCA
PHAT	- 0.29	EWTX

Risk-Adjusted Indicators

There is a big difference between Tarsus Stock performing well and Tarsus Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tarsus Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
VRCA	4.71	0.69	0.13	0.67	4.50	(6.23)	13.21	(8.89)	28.86
IVA	3.19	0.03	(0.03)	(1.41)	3.60	(3.55)	6.78	(6.58)	18.33
EWTX	2.40	0.21	0.01	(1.25)	3.36	(2.39)	5.66	(3.95)	22.67
VIGL	8.46	4.82	0.97	(1.23)	1.69	(10.38)	9.38	(3.12)	241.38
PRAX	2.56	0.93	0.29	2.17	2.19	(2.97)	7.30	(3.19)	23.00
FDMT	4.26	0.91	0.13	(0.75)	4.61	(4.79)	10.47	(6.84)	25.24
PHAT	6.43	1.36	0.20	1.72	6.03	(8.41)	10.95	(10.96)	99.31
INBX	3.20	0.98	0.23	2.58	3.18	(3.83)	7.99	(4.71)	15.98

Tarsus Pharmaceuticals Corporate Management

Leonard JD	Chief Officer	Profile
Scott Youmans	Vice Sales	Profile
Seshadri Neervannan	Chief Officer	Profile
Adrienne Kemp	Senior Communications	Profile
Elizabeth MD	Chief Director	Profile
Aziz MBA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC